Skip to content

Cerus CERS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

CorMedix logo
CorMedixCRMD
$0-100%
Haemonetics logo
HaemoneticsHAE
$1.15M+127%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$3.4M-20.9%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$23.37M+96.1%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$1.8M-40.0%
ADMA Biologics logo
ADMA BiologicsADMA
$588K+482%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's stock issuance proceeds?
Cerus (CERS) reported stock issuance proceeds of $0 in Q1 2026.
How has Cerus's stock issuance proceeds changed year-over-year?
Cerus's stock issuance proceeds increased by 100.0% year-over-year, from -$56K to $0.
What is the long-term trend for Cerus's stock issuance proceeds?
Over 2 years (2021 to 2024), Cerus's stock issuance proceeds has grown at a -77.7% compound annual growth rate (CAGR), from $2.74M to -$137K.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.